Photo from KidneyCAN/LinkedIn
Jul 11, 2024, 18:09
KidneyCAN thanks its partners
KidneyCAN shared on LinkedIn:
“Huge shoutout to our KCRS24 Research Partners: AVEO Oncology and Merck.
Your commitment to accelerating cures for kidney cancer is making a real impact. Here’s to more breakthroughs and lives saved!”
Source: KidneyCAN/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14